Conavi Medical Reports Fiscal Q3 2025 Interim Results and Operational Highlights
US FDA 510(k) submission remains on track for calendar Q3 2025Successful validation testing of Novasight Hybrid™ system with key opinion leaders Recent academic publications underscore importance of intravascular imaging and…